No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma

Author:

Knight Tristan E.,Ahn Kwang Woo,Hebert Kyle M.,Atshan Rasha,Wall Donna A.,Chiengthong Kanhatai,Lund Troy C.ORCID,Prestidge TimORCID,Rangarajan Hemalatha G.ORCID,Dvorak Christopher C.ORCID,Auletta Jeffery J.,Kent MichaelORCID,Hashem HasanORCID,Talano Julie-An,Rotz Seth J.ORCID,Fraint EllenORCID,Myers Kasiani C.ORCID,Leung Wing,Sharma AkshayORCID,Bhatt Neel S.ORCID,Driscoll Timothy A.,Yu Lolie C.,Schultz Kirk R.ORCID,Qayed Muna,Broglie LarisaORCID,Eapen Mary,Yanik Gregory A.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Reference11 articles.

1. Pavone V, Gaudio F, Console G, Vitolo U, Iacopino P, Guarini A, et al. Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation. Bone Marrow Transpl. 2006;37:719–24. https://doi.org/10.1038/sj.bmt.1705298

2. Costa LJ, Nista EJ, Buadi FK, Lacy MQ, Dispenzieri A, Kramer CP, et al. Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratification. Biol Blood Marrow Transpl. 2014;20:222–8. https://doi.org/10.1016/j.bbmt.2013.11.003

3. Ravoet C, Feremans W, Husson B, Majois F, Kentos A, Lambermont M, et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transpl. 1996;18:943–7.

4. Palomo M, Diaz-Ricart M, Carbo C, Rovira M, Fernandez-Aviles F, Martine C, et al. Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl. 2010;16:985–93. https://doi.org/10.1016/j.bbmt.2010.02.008

5. Morgenstern DA, London WB, Stephens D, Volchenboum SL, Simon T, Nakagawara A, et al. Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: a study from the International Neuroblastoma Risk Group database. Eur J Cancer Oxf Engl 1990. 2016;65:1–10. https://doi.org/10.1016/j.ejca.2016.06.005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3